Edico Genome (San Diego), a young company developing a bioinformatics chip to speed data analysis and lower costs of genome sequencing, has raised $10 million in Series A financing to commercialize its Dragen Bio-IT processor. The financing was led by Qualcomm through its venture investment group, Qualcomm Ventures, and included Axon Ventures and Greg Lucier, who made his first investment following his role as CEO/chairman of Life Technologies. Read More
